Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02949921 · ClinicalTrials.gov registry record · NA
Radiological Evaluation of Radiesse Implantation in the Hands
A NA study of Volume Loss in the Dorsum of the Hand, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02949921 is a NA study of Volume Loss in the Dorsum of the Hand that has completed, run by Merz North America. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02949921, a NA study of Volume Loss in the Dorsum of the Hand, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to provide a preliminary assessment of the radiographic appearance of Radiesse material that has been injected into the dorsum of the hands.
Conditions Studied
Interventions
- DEVICE Radiesse injectable implant and 2% lidocaine HCL
Study Locations (1)
California
- Merz Investigative Site #0010358 - Vista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-12-01 |
| Est. Completion | 2018-01-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02949921
The ClinicalTrials.gov registry entry for NCT02949921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Volume Loss in the Dorsum of the Hand appearing as the primary indexed condition, and to 1 intervention - of which Radiesse injectable implant and 2% lidocaine HCL is the first listed.
NCT02949921 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02949921 about?
NCT02949921 is a clinical study titled "Radiological Evaluation of Radiesse Implantation in the Hands". The objective of this study is to provide a preliminary assessment of the radiographic appearance of Radiesse material that has been injected into the dorsum of the hands.
What is the current status of trial NCT02949921?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-12-01. Estimated completion is 2018-01-02.
What conditions does trial NCT02949921 study?
This clinical trial studies the following conditions: Volume Loss in the Dorsum of the Hand.
What interventions are being tested in trial NCT02949921?
The interventions under investigation include: Radiesse injectable implant and 2% lidocaine HCL (DEVICE).
Who is sponsoring clinical trial NCT02949921?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02949921 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Volume Loss in the Dorsum of the Hand
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.